Adar1 Capital Management, LLC Silence Therapeutics PLC Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 40,290 shares of SLN stock, worth $277,195. This represents 0.12% of its overall portfolio holdings.
Number of Shares
40,290
Previous 40,290
-0.0%
Holding current value
$277,195
Previous $766 Million
4.32%
% of portfolio
0.12%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding SLN
# of Institutions
71Shares Held
28.1MCall Options Held
300Put Options Held
2K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$20.9 Million7.16% of portfolio
-
Siren, L.L.C. New York, NY2.83MShares$19.5 Million2.57% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY2.66MShares$18.3 Million3.3% of portfolio
-
Redmile Group, LLC San Francisco, CA1.9MShares$13.1 Million2.26% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.15MShares$7.9 Million1.12% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $247M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...